Abstract |
Immunotherapy is a powerful tool for cancer treatment, but the pleiotropic nature of cytokines and immunological agents strongly limits clinical translation and safety. To address this unmet need, we designed and characterised a systemically targeted cytokine gene delivery system through transmorphic encapsidation of human recombinant adeno-associated virus DNA using coat proteins from a tumour-targeted bacteriophage (phage). We show that Transmorphic Phage/AAV (TPA) particles provide superior delivery of transgenes over current phage-derived vectors through greater diffusion across the extracellular space and improved intracellular trafficking. We used TPA to target the delivery of cytokine-encoding transgenes for interleukin-12 ( IL12), and novel isoforms of IL15 and tumour necrosis factor alpha (TNF α ) for tumour immunotherapy. Our results demonstrate selective and efficient gene delivery and immunotherapy against solid tumours in vivo, without harming healthy organs. Our transmorphic particle system provides a promising modality for safe and effective gene delivery, and cancer immunotherapies through cross-species complementation of two commonly used viruses.
|
Authors | Paladd Asavarut, Sajee Waramit, Keittisak Suwan, Gert J K Marais, Aitthiphon Chongchai, Surachet Benjathummarak, Mariam Al-Bahrani, Paula Vila-Gomez, Matthew Williams, Prachya Kongtawelert, Teerapong Yata, Amin Hajitou |
Journal | EMBO molecular medicine
(EMBO Mol Med)
Vol. 14
Issue 8
Pg. e15418
(08 08 2022)
ISSN: 1757-4684 [Electronic] England |
PMID | 35758207
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 The Authors. Published under the terms of the CC BY 4.0 license. |
Chemical References |
|
Topics |
- Bacteriophages
(genetics)
- Cytokines
(metabolism)
- Dependovirus
(genetics)
- Gene Transfer Techniques
- Genetic Vectors
- Humans
- Immunotherapy
- Neoplasms
(genetics, therapy)
- Transgenes
|